Background: Thiamine along with other B vitamins has been prescribed since long for treatment of various painful conditions, though individual effects of thiamine on nociception and inflammation are yet to be clearly demonstrated. Objective: To assess the effects of increasing doses of thiamine supplementation against pain and inflammation. Methods: This experimental study was conducted in the Department of Physiology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka from March 2014 to February 2015. Total twenty four male Long Evans rats weighing (200±20 gm) were treated with three different doses of thiamine hydrochloride (THCL 100, 200, 250, mg/kg/day; experimental) or normal saline (5 ml/kg/day; control) intraperitoneally for 7 consecutive days. To evaluate the thiamine's effect on nociceptive pain, early phase (0-5 minutes) and on inflammatory pain, late phase (16-60 minutes) of the formalin test, were observed. In both phases, total frequency of jerking and total duration of flexing and licking of the right hind paw were counted after administration of subcutaneous formalin (50 µl, 2.5%) injection. After formalin test, all the rats were also subjected to formalin induced paw edema test using a water plethysmometer to observe the antiinflammatory effect of thiamine. Statistical analysis was done by ANOVA, followed by Bonferroni post hoc test. In the interpretation of results, p≤0.05 was considered as significant. Results: In formalin test, thiamine lowered frequency of jerking (after all 3 doses, in both phases) and duration of flexing and licking (200 mg/kg -p<0.001, in late phases; 250 mg/kg (p<0.001), in both phases) significantly. Additionally, thiamine lowered paw edema significantly (p<0.001) in higher 2 doses. Conclusion: This study concludes that, thiamine may have dose dependent antinociceptive and anti-inflammatory effects.
mong the water soluble vitamin B complex, Thiamine (B 1 ) was isolated in 1930s and was one of the first system 3 in the present world. It is used in biosynthesis of different neurotransmitters, such as, acetylcholine and gamma-aminobutyric acid (GABA) in addition to its role as a coenzyme 4 . Thiamine deficiency may cause insomnia, fatigue, constipation, gastrointestinal distress, muscular atrophy, cramps in addition to beriberi (Wernicke-Korsakoff syndrome) with central as well as peripheral nervous and cardiovascular symptoms leading to death 5 .
Thiamine with B 6 and B 12 , have been prescribed for long, either alone or with other analgesics, for treatment of various painful conditions, which are not associated with their deficiencies, such as polyneuropathy, neuritis, painful vertebral syndrome, rheumatic diseases, carpal tunnel syndrome as well as premenstrual tension [6] [7] [8] . However, it has been proposed that, high therapeutic doses of B vitamins might be needed to be administered to exert their complete analgesic, antinociceptive or anti-inflammatory effects [9] [10] [11] . Several studies have shown that high doses of thiamine with vitamin B 6 and B 12 , potentiate the antinociceptive effect of diclofenac, ketorolac, ketoprofen as well as acetaminophen [12] [13] [14] [15] . Furthermore, in several animal studies combined thiamine, B6 and B12 have been found effective to reduce nociceptive and inflammatory pain, both after single (acute) as well as after chronic administrations (for ³ 7consecutive days) 9, 13, [15] [16] [17] [18] [19] .
It is noteworthy that, rats treated with high doses of B vitamins have not shown any toxic effects 20 . Moreover, repetitive (chronic) administrations of the B vitamins produced long term inhibition of both severity and duration of pain 20 . Recently, the analgesic and anti-inflammatory effects of thiamine have been demonstrated in different types of animals and the acute and chronic antinociceptive effect of thiamine was evaluated by hot plate test in mice model 21, 22 . In addition, 125 mg/kg/body weight of thiamine decreased acute inflammation in the animals' ear induced by xylene 21 . However, Franca et al. have shown that, thiamine at chronic (for ³ 7consecutive days administration) doses with 50 and 100 mg/kg/ body weight, reduced pain in the second phase (16th to 30th minutes) of formalin test 16 . Similar trend of decrement in the inflammatory pain after administration of different doses of combination of thiamine, B6 and B12 have been reported in several studies 13, 15, 17, 18 .
Formalin test is one of the valid and reliable animal models to assess both the nociceptive as well as inflammatory form of pain and is sensitive to both centrally as well as peripherally acting analgesics 23, 24 . Here, subcutaneous injection of formalin at hindpaw induces inflammation, which leads to a response characterized by jerking, flexing followed by licking of the affected hindlimb 23, 25, 26 . Pain intensity is measured by converting these behavioral responses into numerical values 24, 25, 26, 27 , assessed in early phase (first 5-7 minutes, results from direct chemical stimulation of the nociceptive afferent fibers mainly C fibers) 28 , while the late phase (last 40-45 minutes, results from the action of locally released inflammatory mediators and also by the facilitation of synaptic transmission in thespinalcord) 29 .
In addition, the formalin induced paw edema test in rodents is a very simple, accurate and one of the common models for the assessment of inflammation in animals 30, 31, 32 , where the characteristic hindpaw edema has been associated with increased amount of chemical mediators in tissue fluids 31 .
In recent years, various researchers have intended to find out alternatives to the conventional analgesics in order to replace them with natural substances, or to decrease their doses to minimize their adverse effects. Though antinociceptive and anti-inflammatory effects of thiamine with different doses and duration were reported but there is lack of information about the potency of aforementioned effects with higher doses along with chronic administration of this vitamin. Therefore, this study was designed to evaluate the antinociceptive as well as anti-inflammatory effects of chronic (single daily dose for 7 consecutive days) supplementations of thiamine in increasing doses (100, 200 and 250 mg/kg of body weight) by formalin test and formalin induced paw edema test, in rats. 16, 20, 22, 30, [37] [38] : The rats were acclimatized in the experimental laboratory environment, in the observation cage of the plexiglass formalin box (30×30×30 cm3) for 1 hour daily (within 8:00 to 14:00 hours) for 7 consecutive days prior to the formalin test. Then on the day of experiment (Day 7), 1 hour after last dose of (i.p.) injection of THCL or equal volume of NS, the rats were restrained by a thick towel and 50 µl of dilute formalin (2.5%) was injected subcutaneously into the plantar aspect of the rats' right hindpaw with an insulin syringe. Immediately thereafter, the animal was placed in the observation cage of the formalin box and the pain behaviors were observed for 60 consecutive minutes. Within this time the first 5 minutes (1st -5th) was considered as the early phase, and last 45 minutes (16th -60th) as the late phase. Observation was made by counting the total frequency of jerking and total duration of flexing plus licking of the injected paw during this time through a mirror fixed below the formalin box at 45Ú angle. A stop watch was used to note the time.
Methods
Formalin induced paw edema test 16, 31, 39 : Anti-inflammatory effect of thiamine was determined by the formalin induced paw edema model, where the amount of paw edema resulted from intra-planter injection of 50 µl of 2.5% formalin was used an indicator of inflammation severity. Following 60 minutes of recording the pain behaviors (about 120 minutes after the i.p administration of THCL or NS), the animal was sacrificed. Then the volumes of the animal's right and left hind paws were measured by using a water plethysmometer. Left paw volume was subtracted from right paw volume to attain the net edema volume.
Data were expressed as mean±SEM and statistically analyzed by SPSS (version 17.0) using analysis of variance (ANOVA), followed by a Bonferroni Post hoc test. In the interpretation of results, p value ≤ 0.05 was considered as significant.
Results
In this study, THCL significantly reduced the jerking frequency (p ≤ 0.001, in all doses) and flexing and licking duration (p ≤ 0.001, in 250mg/kg) in the early phase of formalin test (Figure 1 ).
In addition, this vitamin also reduced the jerking frequency (p ≤ 0.001, in all doses) as well as the duration of flexing and licking (p ≤ 0.001, in 200 
Discussion
In this study, thiamine supplementation in chronic (consecutive 7 days) administration elicited potent antinociceptive effects, as evidenced by significant lowering of jerking frequency as well as duration of flexing and licking in both phases of formalin test in experimental rats. Similar trend of findings has been observed by Franca et al. 16 , though they investigated the effect of administration of individual thiamine as well as combined (20:20:1) thiamine, pyridoxine and cyanocobalamine (TPC), both at 50 and 100 mg/ kg (i.p.). Furthermore decrement of pain response was also reported by other researchers after single oral administration of TPC at different doses in different pain models 13, 18, 19 .
Again, in this study, chronic supplementation of B 1 (200 and 250 mg/kg) significantly lowered the edema in the formalin induced paw edema test. Similar observations were reported by Moallem and his colleagues after single supplementation of B 1 alone 21 and also by Franca et al. after chronic supplementation of combined B 1 , B 12 and B 6 in mice models in different dosage from this study 16 .
The exact possible mechanisms regarding these observed effects cannot not be revealed directly from the present study. However, several investigators of different countries proposed various suggestions on these aspects, which might be cause of our present findings. It has been suggested that, antinociceptive effect of THCL may be due to increase inhibitory control of afferent nociceptive neurons at the spinal cord along with decrease response of thalamic neurons to nociceptive stimulation 40, 41 . Moreover, thiamine supplementation may also increase the availability or effectiveness of serotonin as well as noradrenaline in the CNS 24, 26, 27 . Besides the central effects in lowering nociception, it has been proposed that peripheral anti-inflammatory effect of this vitamin may be mediated through regulation of arachidonic acid pathway in macrophage, where it can block the expression of any of the enzymes (cycloxygenase-2, lipoxygenase-2, thromboxane B synthase, prostacycline synthase) as well as transcription factor nuclear factor kappa 28 . In addition, this vitamin may also decrease the oxidative stress and production of free radicals 29 .
As, all 3 doses of THCL(100, 200 and 250 mg/ kg) in our study significantly lowered the early and late phases of formalin test, it is suggestive that all those doses possess both the central and peripheral antinociceptive effects. Along with this, significant reduction of formalin induced hind paw edema after THCL administration, suggested its probable role in amelioration of inflammation and thereby inflammatory pain with higher two doses of (200 and 250 mg/kg). In addition all these effects of B 1 on lowering pain and inflammation in the present study were related with the dose of supplementation, as evidenced by more decrement of all the study variables in the higher dose (250 mg/kg/day) group. It is suggested that, chronic supplementation at progressively higher doses might cause more accumulation of B 1 in the serum which probably exerted a cumulative effect for greater decrement of pain and inflammatory variables in our study. Strikingly, the lowest dose (100 mg/kg) of THCL used in our study did not lower the paw edema significantly, whereas it inhibited the jerking frequency significantly in the late phase of formalin test. These findings incite our thinking that B 1 may possess any other mechanism of decrement of inflammatory pain other than anti-inflammation.
Conclusion
In conclusion, it is recommended that, chronic thiamine supplementation may diminish both the acute and chronic forms of nociception and may have potent role against inflammation, which are dose dependent. However, further experimental study is recommended to elucidate the exact mechanism responsible for these effects. 
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